Fiche centre
Foothills Medical Centre
Calgary — Canada
Essais liés2clinical trials
VilleCalgarylocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT01194570
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| PREDICT — Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX® | Migraine | À vérifier | NCT02502123 | PREDICT — Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX® | COMPLETED |
| Ocrelizumab | SEP | Phase 3 | NCT01194570 | ORATORIO — A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis | COMPLETED |